Nevas Life Sciences Private Limited
About Nevas Life Sciences Private Limited
Data last updated:
Nevas Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 August 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2022PTC165329.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jangili Nipun Kumar and Anil Kumar Salandra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 – 7 – 112/86 Keshava Nagar Colony New Mettuguda, Hyderabad, Telangana, India – 500017.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.77 Lakh. For the same year it recorded a net profit of ₹1,000 (net margin 0.1%) and EBITDA of ₹1,430 (EBITDA margin 0.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address12 – 7 – 112/86 Keshava Nagar Colony New Mettuguda, Hyderabad, Telangana, India – 500017
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nevas Life Sciences Private Limited
The main business activity of Nevas Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nevas Life Sciences Private Limited FY 2025 filings available
Nevas Life Sciences Private Limited reported revenue of ₹15.77 Lakh for FY 2024.
Financial Statement Summary of Nevas Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹1,430 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹1,000 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Nevas Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.1% | •••• |
| Net Profit Margin | 0.1% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nevas Life Sciences are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nevas Life Sciences Private Limited
Nevas Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jangili Nipun Kumar | Director | 01 Aug 2022 | 4 Years 2 Months | Current |
| Anil Kumar Salandra | Director | 01 Aug 2022 | 4 Years 2 Months | Current |
Peer Comparison of Nevas Life Sciences Private Limited
Nevas Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aauris Healthcare Private Limited | ₹16.14 Lakh (FY 2025) | •••• | •••• | 1957.0% | •••• | Kolkata, West Bengal, India |
| Lyfgen Pharmaceuticals Private Limited | ₹16.12 Lakh (FY 2021) | •••• | •••• | 43.0% | •••• | New Delhi, Delhi, India |
| Novetra Laboratories Private Limited | ₹16.04 Lakh (FY 2025) | •••• | •••• | 6460.0% | •••• | Thane, Maharashtra, India |
| Variety Formulations Pvt Ltd | ₹15.86 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Palghat, Kerala, India |
| Avenida Healthcare Private Limited | ₹15.82 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Kolkata, West Bengal, India |
| Nevas Life Sciences Private Limited this company | ₹15.77 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Eco-Dynamic Sun Chemcon Private Limited | ₹15.72 Lakh (FY 2024) | •••• | •••• | -4.0% | •••• | Nashik, Maharashtra, India |
| Vindhyan Ayurvedic Pharmaceuticals Pvt Ltd | ₹15.64 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Ernakulam, Kerala, India |
| Revolutionlife Pharmaceuticals Private Limited | ₹15.53 Lakh (FY 2020) | •••• | •••• | 41.0% | •••• | Lucknow, Uttar Pradesh, India |
| Maitree Research Private Limited | ₹15.5 Lakh (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Baljiwan Herbal Care Private Limited | ₹15.5 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Nevas Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Nevas Life Sciences Private Limited
Nevas Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nevas Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Nevas Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nevas Life Sciences Private Limited
Nevas Life Sciences Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Anil Kumar Salandra was appointed as Director on 01 Aug 2022.
Credit Ratings, Litigation & Regulatory Alerts for Nevas Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nevas Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nevas Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nevas Life Sciences Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nevas Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nevas Life Sciences Private Limited
Nevas Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 August 2022 (4+ years old) and is registered under CIN U24239TG2022PTC165329.
Nevas Life Sciences reported revenue of ₹15.77 Lakh for FY 2024.
Nevas Life Sciences has 2 current directors:
- Jangili Nipun Kumar - Director
- Anil Kumar Salandra - Director
Nevas Life Sciences reported a net profit of ₹1,000 (net margin 0.1%) and EBITDA of ₹1,430 (EBITDA margin 0.1%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Nevas Life Sciences is U24239TG2022PTC165329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nevas Life Sciences was incorporated on 01 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nevas Life Sciences by revenue are Aauris Healthcare Private Limited, Lyfgen Pharmaceuticals Private Limited, Novetra Laboratories Private Limited, Variety Formulations Pvt Ltd, Avenida Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Anil Kumar Salandra was appointed as Director on 01 Aug 2022. Jangili Nipun Kumar was appointed as Director on 01 Aug 2022.
The registered office of Nevas Life Sciences is at 12 – 7 – 11286 Keshava Nagar Colony New Mettuguda, Hyderabad, Telangana, India – 500017.
Nevas Life Sciences has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Nevas Life Sciences operates in the pharma industry, in the drug formulation and development segment.